The Penny Picks | Penny Space Under the Spotlight; ASX 200 marks fresh 100-day high

ASX 200 is edging higher on the second day of the month.  Defying inflation expectations and virus concerns, commodity supercycle and economic recovery prospects are fuelling the market momentum. Australian shares rose on Wednesday amid GDP data reflecting the country's economy continued to grow in the first quarter. 

Australian economic activity has recovered to be above pre-pandemic levels and has grown 1.1 per cent through the year. While the optimistic economy scenario is interesting to note, the frequent upbeat economic data seems to have again stoked investors’ concerns that rising inflation may lead the global Central Banks to unwind its stimulus measures. ASX energy stocks witness best day in 2 months amid favourable oil price dynamics.

Then, a huge surge in iron ore price seems to be a catalyst for iron ore miners Australian pharmaceutical company Amplia Therapeutics, developing new approaches for the treatment of cancer and fibrosis, has received new data from its collaboration with Professor Paul Timpson of the Garvan Institute of Medical Research.

Moving on, the share price of clinical-stage biotechnology company Actinogen Medical hits over 6-yr high on approval for Alzheimer's study. The Company has approval for Xana-MIA study from Bellberry Human Research Ethics Committee (HREC) to treat patients with Alzheimer's disease. Next, Australia's Clean Seas  gained on obtaining nod for new farming location. 

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK